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Abstract 
 
A descriptive study was initiated to investigate the use of peppermint oil to reduce the 
nausea of the palliative care and hospice patient. Two local palliative care and hospice 
programs were used as sites for the study.  Patients eighteen and older complaining of 
nausea were invited to participate in the study.  The study was conducted for one and a 
half months. A total of eight patients consented to participate in the study with a mean 
age of seventy one years. The Bieri Scale, a visual-numeric analog, was used as the 
measurement instrument for the patients to evaluate their nausea. Results showed that 
peppermint oil may augment other medications.  Eighty-eight percent reported a 
decrease in the level of nausea following the use of conventional medication as well as 
the use of medication and peppermint oil. 
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Chapter I 
 
Introduction 
 
Hospice and palliative care is defined by Mechelen et al., (2012) as the comfort 
provided to patients diagnosed with a progressive, life-threatening disease with no 
possibility of obtaining remission, or stabilization, or modifying the course of the illness. 
The major goal of Palliative care and Hospice is to provide comfort at the end of life that 
support quality of life.  A variety of services are offered that focus on supporting quality 
of life through symptom control.  A very debilitating complaint for many of these 
patients is nausea.  Thus, Palliative care and Hospice providers may use a variety of 
methods including complementary medications such as aromatherapy to treat nausea. 
Statement of the Problem  
For the palliative care and hospice patient, nausea is a frequent complaint. The 
most frequent cause is the progression of the disease. Many kinds of cancers and 
wasting syndrome in terminal AIDS involve the digestive tract, which involves the 
stomach, various parts of the colon, spleen, bile duct, and gall bladder. With advanced 
cancer, nausea may have more than one cause which may be stimulated by more than 
one pathway. There are also some brain cancers that affect the digestive tract.  Often for 
these patients, the only relief of nausea is when the individual experiences an episode of 
emesis (Doyle, Hanks, & MacDonald, 1998).  
  The second most common cause of nausea in the palliative care and hospice 
patient is medications.  The nausea may be from chemotherapy and/or radiation that they 
received before palliative care and hospice became involved with their care. Nausea may 
also be caused by viral and bacterial infections (Gilligan, 2005). If untreated, nausea 
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may cause many medical problems, including, poor nutrition, dehydration, electrolyte 
imbalance, as well as physical and mental deterioration (Hamadini et al., 2007).  
Medications may need to be limited due to drug interactions.  Thus, the use of nondrug 
measures is important in the management of nausea and vomiting in palliative care 
(Glare, Miller, Nikolova, & Tickoo, 2011) 
Many patients turn to aromatherapy when receiving radiation, or chemotherapy, 
and when dealing with end of life issues. In order to avoid the potentially negative 
interaction with the clients’ medical treatment, the essential oil must be applied safely.  
Applying the essential oil directly to the skin may cause irritation. Safety testing on 
essential oils has been found that they have very few bad side effects occur. Research 
supports that aromatherapy can be highly effective to manage restlessness, anxiety, and 
stress.   Evidence does not support the claims that aromatherapy cures or prevents cancer 
(National Cancer Institute, 2010). 
 A few trials suggest that aromatherapy may be helpful as a complementary 
therapy.  Research has studied the effect of aromatherapy on other health conditions, and 
quality of life issues, such as cancer related symptoms, stress, anxiety. Essential oils can 
be used to support and balance the mind, body, and spirit.  The cancer patient may use 
aromatherapy as supportive care to improve their quality of life, and to decrease their 
stress, and anxiety.  Indirect inhalation may be used for the patient to breathe in the 
essential oil by using a room diffuser or by placing a few drops nearby, or for massage 
therapy.  Essential oils are rarely taken by mouth (National Institute of Health, 2011). 
 The use of aromatherapy in the hospice and palliative care setting has not been 
fully explored.  Non-drug measures can play an important role in the management of 
3 
 
 
 
nausea and vomiting. The use of aromatherapy may decrease the need for medication in 
a cancer patient. Some patients have reported an improvement in symptoms, such as 
nausea, or pain (National Institute of Health, 2011). 
Purpose of the Study 
   The use of peppermint oils have been recognized as an effective treatment for 
controlling nausea in general (Hines, Steels, Chang, & Gibbons, 2009)  The essential oil, 
Peppermint Oil, is sometimes used to reduce the level of nausea for patients enrolled in 
Palliative Care and Hospice.  Thus, the purpose of this pilot study is to examine the 
effectiveness of the use of peppermint oil as an alternative and /or complementary 
therapy for patients enrolled in a local Palliative Care and Hospice program and to 
answer the question. Does the use of peppermint oil relive the nausea in the palliative 
care and hospice patient? 
Background and Significance 
  The use of peppermint oil has been used in aromatherapy and dates back to 
ancient Egypt, China, and India.  The Greeks and Romans used fragrant oils for both 
medicinal and cosmetic purposes.  It was not until the 1980’s that it began to become 
popular in the United States (American Cancer Society, (ACS), 2011). 
While peppermint oil has been helpful in the surgical arena to relieve nausea, 
further investigation in the role of aromatherapy in the hospice and palliative care 
patient is needed.  The challenge of aromatherapy is to broaden the base of experience in 
using the therapy in specific settings, not only focusing on  the scientific and physical 
results of the aromatherapy, but also,  how it affects the whole patient (Gilligan, 2005). 
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Orlando’s Conceptual Framework 
 Orlando‘s (1961) theory of deliberate nursing, stresses the relationship between 
the patient and the nurse.  Orlando was one of the first nursing leaders to emphasize the 
elements  or the nursing process and critical importance of the patient’s participation 
providing direct assistance to individuals in whatever setting for the purpose of 
avoiding, reliving, diminishing  or curing the person’s sense of hopelessness (Forchuk, 
1991). Orlando states that nursing’s purpose is to supply the help a patient requires in 
order for his or her needs to be met (1961). Nursing actions are derived from the 
patient’s immediate experience and immediate need.  The nurse must meet the patient’s 
needs directly by her own actions or by calling for help.  The palliative care and hospice 
patient often are not able to verbally express their needs. The nurse should help relieve 
the physical or mental discomfort and should not add to the patient’s distress. 
The professional nurse must continue to look for ways to improve the care of the 
patient. In this study, smelling peppermint oil placed on a cotton ball is a safe and 
inexpensive intervention to meet the patients’ immediate relief of nausea.  The patient 
may also, experience a decrease in their anxiety level.  This may enable them to have 
quality time with family and friends. 
Research Question 
Does the use of peppermint oil decrease the nausea of the palliative care and hospice 
patient? 
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Chapter II 
Review of the Literature 
 
 Review of the literature included Ebsco.com (Cinahl Plus with Full Text), 
Medline Plus, Medline Central, PubMed, Elsevier Health Sciences, Science Direct, and 
Wiley Online Library. 
Aromatherapy in post-operative patients/digestive disorders  
Nausea has been defined as more distressing than vomiting. The effect on the 
cancer patient can be considerable. It can adversely affect the patient’s quality of life, 
and the ability to perform their activities of daily living (Bloechil-Daum, Deuson, 
Mavros, Hansen, & Herrstedt, 2006).   
Peppermint oil has been shown to decrease the need for medication in the post-
surgery patient. By placing the peppermint oil on a cotton swab and waving it under the 
individual’s nostrils the need for antiemetic was reduced. Although, Garrett, Tsuruta, 
Walker, Jackson, and Sweat, (2003) did not find the use of peppermint oil to be 
statistically significant in the post-operative patients; the experimental group did have a 
lower prevalence, and /or intensity of nausea after surgery. Patients required less 
antiemetic medications, and were more tolerant to analgesia (can cause nausea) (Garrett 
et al., 2003).  
A systematic review and meta-analysis to examine the effect of fiber, 
antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome was 
conducted in 2008 (Ford).  The trials were randomized control trials for fiber, bran, 
ispaghual, antispasmodics, and peppermint oil versus a placebo. Four trials compared 
peppermint oil to a placebo. The study included 392 patients. The proportion of women 
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in each trial ranged from 40-76%. Fifty two of 197 (26%) patients randomized to 
peppermint oil had persistent symptoms compared with 127 of 195 (65%) receiving 
placebo (relative risk 0.43, 0.32 to 0.59) with statistically significant heterogeneity 
detected between studies (I2=31.1%, P=0.23).  The number needed to treat with 
peppermint oil to prevent one patient having persistent symptoms was 2.5 (2.0 to 3.0). 
The conclusion reached was that peppermint oil was more effective than the placebo 
(Ford et al., 2008). 
 Kligler and Chuedhary (2007) discussed the long history of using the peppermint 
leaf and oil for digestive disorders. This list includes Irritable Bowel Syndrome, 
headaches, and non-ulcer dyspepsia.  The extracts are used as flavoring for toothpastes 
and mouthwashes, and over the counter gastrointestinal products. In vitro research 
shows that the pill by mouth to be effective in relaxing the gastrointestinal smooth 
muscles, possibly through the antagonistic effect on the Calcium channels in the gut. It 
has been shown that the oral peppermint oil relaxes the lower esophageal sphincter, 
which can result in gastroesophageal reflux.  The contraindications for the oral form are 
that it is lethal and toxic are excessive dosages. It has been associated with interstitial 
nephritis and acute renal failure (Kligler & Chuedhary, 2007). 
Aromatherapy in cancer patients/hospice and palliative patients 
The National Institute of Health (NIH) has begun research to determine if the use 
of peppermint oil will reduce nausea in the cancer patient receiving chemotherapy.  The 
NIH facilitates research evaluation of complementary and alternative practices.  It 
provides information on a variety of approaches to care for the health professional and 
also, the public (NIH, 2011). 
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A recurring study of the National Institute of Health involves a randomized trial 
of the effectiveness of aromatherapy on chemotherapy induced nausea, and vomiting in 
children with cancer.  The medical conditions included in the study are: Brain tumors, 
Leukemia, Sarcomas, Neuroblastoma, Lymphoma, and Hodgkin’s disease. The 
intervention used is an aroma wand versus a placebo wand. The trial is ongoing. No data 
has been published at this time (Whitfield & Shulman, 2009). 
Smith (2011) conducted a double blind peer review in Europe, and a peer review 
in the United Kingdom and Ireland, to confirm that peppermint oil has an antispasmodic, 
antimicrobial and antiseptic action. However, due to methodological flaws, no 
conclusions could be established.  Smith recommended that a better designed trial is 
required to determine the potential effect of peppermint oil in Irritable Bowel Syndrome 
(Smith, 2011). 
Gilligan (2005) conducted a twelve month study of palliative care and hospice 
patients receiving specific aromatherapy treatments to address the symptom of nausea.  
Findings of the study indicated that the majority of patients, in the advanced stages of 
their illness, did experience some relief of their nausea. However, newly admitted 
patients did not experience a difference in their nausea using the aromatherapy.  More 
favorable responses were obtained using a synergy of essential oils than individual ones 
(Gilligan, 2005). 
Summary 
Nausea remains a major concern for the palliative care and hospice patient.   The 
literature reveals that peppermint oil may decrease the nausea of some patients and also 
may help decrease the anxiety they may be experiencing as well.  However, a review of 
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the literature revealed little data on the use of peppermint oil as an adjunct for the relief 
of nausea for the patient enrolled in a palliative care and hospice program.  Thus, further 
research is needed to establish the various uses of peppermint oil in this setting. 
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Chapter III 
      Method 
The methodological design for this pilot study was a quantitative, descriptive 
design. The setting included two local palliative care and hospice facilities in western 
North Carolina. A convenience sampling plan was utilized in obtaining participants for 
the study. 
Sample 
 A convenience sample of 15 patients enrolled in palliative care and hospice 
services, eighteen years and older who were experiencing nausea and were able to 
provide consent to participate were invited to participate in the study.  
Ethical Considerations 
The goal of the study was explained to the patient and a family member.  This 
information included the researcher’s name, the advisor, and the IRB (Internal Review 
Board) contact phone numbers (see Appendix A).   
A participating physician, Licensed Independent Practitioner (LIP), or a 
registered nurse assessed each potential participant to determine patient cognitive ability 
to understanding the purpose of the study and if the patient was competent to consent to 
participate in the study (see Appendix B).  Each eligible patient was informed that 
participation in the study was strictly voluntary and that declining to be in the study 
would have no effect on the care received.  Anonymity and confidentiality was 
maintained (see Appendix C).  The patient’s name was not placed on any data collection 
forms or revealed in the results. 
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Procedure 
Data collection using a pretest and a posttest was used to examine the effects of 
peppermint oil to reduce the nausea of the palliative care and hospice patient. Patients 
were asked to rate their level of nausea using the Bieri scale prior to treatment of nausea 
and again after the treatment. With the permission of the patients and family members, 
the intervention of adding one-two drops of peppermint oil on a cotton swab for them to 
smell was added to the treatment regimen. 
A data collection tool was used to record the responses of the patient, using the 
pretest and posttest with each treatment (see Appendix D).  Demographic data of age, 
gender, and length of time in the facility was used to describe the sample collectively.  
All data was entered into the researcher’s computer and was password protected. 
Measurement Instruments 
A Visual Analog Scale (VAS) known as the Bieri Scale (see Appendix E) was 
used to measure nausea.  The Bieri scale uses numbers to measure the level of nausea 
with 0 meaning no nausea, 2 signifying mild nausea, 6 implying moderate nausea, 8 
denoting severe nausea and 10 being the worst possible nausea.  
  Reliability and Validity of the Bieri Scale has been established.  The Bieri scale 
has been widely adapted as a measurement instrument for other symptoms such as pain 
as well.  As far back as 1988, the visual analog scale has been regarded as a simple 
technique for measuring a subjective experience. The visual analog scale has been 
established as a reliable and valid in a range of clinical and research applications 
(McCormack, Horne, & Sheather, 1988).  
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In “Instruments for Clinical Health-Care Research” the visual analog scale 
(VAS) was discussed. Traditionally, the scale has been used without indicators. In recent 
years, it has been used with and without markings. Although the scale avoids language 
to signify graduations of a subjective phenomenon, the anchor extremes require 
meaningful descriptors with tested reliability. As an example: a vomiting VAS anchored 
at none on the low end of the continuum, and at constant retching at the opposite end can 
link two different concepts together. The VAS is a reliable, valid, and sensitive self-
report tool for studying subjective symptoms. Reliability and validity are strengthened 
when a stable phenomenon is being evaluated and a single concept is being measured 
(Frank-Stromborg & Olsen, 2004). 
Hendey, Donner, and Fuller (2005), used a prospective, descriptive study of 
consenting adults who presented to the emergency department with nausea. This study  
was developed to measure a visual analog scale. The objective was to determine the 
minimum clinically significant change in nausea as measured using a visual analog 
scale. Eighty-three paired visual analog scale measurements were collected from 50 
patients.  The minimum clinically significant visual analog scale change in nausea was 
15 mm, which is similar to previous studies of other symptoms, and help in the 
interpretation of clinical studies reporting changes in nausea (Hendey, Donner, & Fuller, 
2005). 
  Collection of data began with the patient’s first complaint of nausea. The 
researcher recorded the pre and post assessment of the nausea and the medication given.  
When the patient complained of nausea the second time, the researcher again assessed 
the level of nausea prior to administering medication.  At this time, the addition of 
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smelling the peppermint oil was added to the intervention, along with the medication if 
the patient requested it.  The patient was able to receive the medication for nausea at any 
time during the procedure. 
All completed instruments were stored in a locked file for safety.  All medical 
record data were entered to a spreadsheet. Only the researcher had access to actual 
medical records by patient name. 
Data Analysis 
           A descriptive analysis was used to summarize the effectiveness of the use of 
peppermint oil to decrease the level of nausea of the palliative care and hospice patient.  
The researcher defined the percentages of the treatments of nausea.  Data were analyzed 
to determine the percentage of nausea relief with and without the use of peppermint oil. 
This data included the treatment of the nausea with only the medication, the introduction 
of the peppermint oil, and the requirement of additional medication.  Descriptive data 
were analyzed using Microsoft Excel. 
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Chapter IV 
 
Results 
 
         Of the 15 patients approached only eight were included in the study.  Of the seven 
patients not included, two patients declined to participate, two complained of nausea 
only once, two did not complain of nausea, and one was in the active stages of dying.  
Ages ranged from 42 -90 with a mean age of 71.  The inpatient days in the palliative 
setting ranged from 1 to 71 with a mean of 16.6 days. There were three males and five 
female participants (see Figure 1).  Assessment of the level of nausea prior to any 
treatment ranged from 0-9 using the Bieri numeric scale.  Two participants expressed a 
nausea level of eight (very severe) prior to treatment; two rated their nausea as a six 
(severe), two persons rated their level as a four (moderate), and one person stated they 
needed something for nausea but gave a 0 (no nausea) as the level of nausea prior to 
treatment. 
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Figure 1.  Percentages of Participants by Gender 
  
62.50% 
37.50% 
Female Male 
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         Assessment of the participant’s level of nausea using the conventional treatment 
ranged from 0 to 5 using the Bieri numeric scale (see Table 1).  
 
 
 
Table 1 
 
Pre-treatment level of nausea, type of conventional medication treatment, and post 
treatment level of nausea. 
  
 
Participants 
Pre-Treatment 
Level of Nausea 
Type of 
conventional 
medication treatment 
 Post – 
Treatment level 
of nausea 
 
Group 1:  1 Male/ 0 
Female 
     6     Phenergan         2 
Group 2: 1 Female/ 0 
Male 
     4    Phenergan/ Ativan               0 
Group 2:  1 Female/0 
Male 
     8      Ativan         0 
Group 3:  1Male/0 
Female 
     4        Haldol          5  
Group 3:    1 Male/ 0 
Female 
     9        Haldol          1 
Group 4:  1 Female/0 
Male 
     2       Prilosec          1 
Group 4:  1 Female/ 0 
Male 
    4        Ativan           1 
Group 4:  1 Female / 0 
Male 
     6      Zofran          5 
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Peppermint oil was added to the treatment for nausea the next time these same 
patients complained of nausea (see Table 2).  Two patients with a pre-nausea level of 4 
and 7 had a decrease level of nausea to 1 and 0 after receiving Haldol 1 mg. by mouth 
and peppermint oil. One patient with a pre-nausea level of 2 received Phenergan 25 mg 
by mouth, and peppermint oil had a post treatment nausea level of 9. Three patients with 
a pre-nausea level of 7 and 4 received peppermint oil only had a decreased level of 
nausea of 0 and 2. Of the eight patients, 88% experienced relief of nausea with the 
conventional medication and peppermint oil; 13% had an increase in nausea; and 38% 
38% stated relief with peppermint oil only.  In assessment of the patients’ level of 
nausea post the addition of the peppermint oil to their regimen, results ranged from 0-2, 
with one outlier patient.  Table 3 shows the means of the nausea level using 
conventional medicine and then using conventional medicine with peppermint oil or 
only peppermint oil.  
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Table 2 
 
Pre-treatment level of nausea, conventional treatment with  addition of peppermint oil, 
and post treatment level of nausea. 
 
 
Participants 
Pre Treatment 
Level of 
Nausea 
Medications 
(Conventional 
treatment plus 
peppermint oil or 
peppermint oil only) 
Post Treatment 
Level of Nausea 
Treatment  Level 
of Nausea 
 
 
Group 1: 1 male /0 
Female 
       2 Phenergan/ 
Peppermint Oil 
       9 
Group 2:  1Female/0 
Male 
       4  Ativan/ 
Peppermint Oil 
        2 
Group 2:  1 Female/ 0 
Male 
        7 Ativan/ Peppermint 
Oil 
        2 
Groups 3: 1 Male/0 
Female 
        0 Haldol/ 
Peppermint Oil 
       0 
Group 3:  1 Male/ 0 
Female 
        8 Haldol/ 
Peppermint Oil 
       1 
Group 4:  1 Female/ 0 
Male 
       4 Peppermint Oil        0 
Group 4:  1 Female/0 
Male 
        7 Peppermint Oil         2 
Group 4:   1 Male/ 
0 Female 
        4 Peppermint Oil         0 
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Table 3 
 
Means of nausea level prior to any medication, following conventional medication, prior 
to treatment with conventional medication and peppermint oil, and following treatment 
with conventional medication and peppermint oil. 
 
Results (n=8)Results (n=8)  Means of Nausea Level Means of 
Nausea Level 
Nausea Prior to Medication  5.6 
 
Nausea following Conventional 
Medication 
 2.25 
Nausea   Prior to Treatment with 
Conventional Medication and 
Peppermint Oil 
 4.6 
Nausea following Treatment with 
Conventional Medication and 
Peppermint Oil 
 2.0 
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Chapter V 
Discussion 
Interpretation of Findings 
 The overall results of the study shows that peppermint oil used in conjunction 
with other medications did help relieve the nausea in the eight patients included in the 
study. Eighty-eight percent (88%) of participates reported a decrease in nausea 
following the use of conventional medications, as well as the use of the conventional 
medication and peppermint oil.  
 This study had similar results in the patient with advanced illness in the palliative 
care and hospice setting as Gilligan’s (2005) study using a variety of essential oils.  Both 
groups did benefit from the addition of the essential oil to the conventional treatment.  
This study adds to the knowledge that non-conventional therapy may augment other 
medications, and that peppermint oil may be useful for relief of nausea of the palliative 
care and hospice patient. 
 The limitations of the study are the small sample size, and the fact that 
conclusions cannot be generalized. 
Implications for Nursing 
 Nursing has an obligation to explore new areas to help improve the quality of life 
for their patients.  The nurse has the responsibility to provide the best evidence practice 
for the patient.  Patients often turn to the nurse for guidance and information about their 
care.  Smelling peppermint oil on a cotton swab is safe, and easy to do.  It has been 
effective in decreasing the nausea of the post-operative patient, and nausea of the patient 
with gastrointestinal problems.   The conclusion of this study found that peppermint oil 
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was successful in decreasing the nausea of the palliative care and hospice patient, 
perhaps peppermint oil as an alternative therapy could be  implemented to meet the 
needs of the patient and to improve the quality of life. 
Implications for Further Research 
 The recommendation is to conduct further studies with the use of peppermint oil 
with a larger sample. Nausea is only one of the many therapeutic uses of peppermint oil.  
Further studies are needed to examine the benefits of this particular aromatherapy. 
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Patient Capacity 
 
 
 
“I examined ___________________________on _____________ for the purpose of 
determining whether he/she is capable of understanding the purpose, nature, risks, 
benefits, and alternatives (including nonparticipation) of the research, making a decision 
about participation, and understanding that the decision about participation in the 
research will involve no penalty or loss of benefits to which the patient is otherwise 
entitled, for _______________’s research project 
_______________________________________________________________________ 
_______________________________________________________________________ 
 
One the basis of this examination I have arrived at the conclusion that 
 (a)   this patient has this capacity at this time                        [ ] 
or (b)  there is doubt about the patient’s capacity at this time   [ ]       
or (c)  this patient clearly lacks this capacity at this time          [ ]   
       
 
[Statement must be signed and dated.] 
 
 
 
See Attached Sheet for Standards of Capacity 
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Standards for Capacity: 
1. The ability to evidence a choice; that is, to communicate a yes or no decision. 
This standard is applicable to all risk/benefit levels. 
 
2, The ability to understand relevant information, that is, the person can tell you 
what the research procedures involve and what the consent information includes 
(e.g., a right to withdraw).  This standard is also applicable to all risk/benefit 
levels. 
 
3. The ability to appreciate the situation and its likely consequences.  The person 
can understand what research participation involves for him or her and what the 
likely outcomes are.  He or she can apply the information to his or her own 
situation.  This standard generally applies to all research involving more than 
minimal risk. 
 
4.  The ability to manipulate information rationally.  This standard focuses on 
process, not outcome. For example, are decisions consistent with the religious, 
moral, and other beliefs of the person?  This standard is critical at the most 
unfavorable risk/ benefit levels. 
 
Questions: 
1. Can you tell me what will happen if you agree to take part in this study? 
2. Will this study help you? 
3. Can you tell me about the possible side effects of the study drug? 
4. Do you have to be in this study? 
5. Can you leave the study once it begins? 
6. What will happen if you decide not to be in this study? 
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Consent for Participation in Study 
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Data Collection  
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Data Assessment Tool:  The Use of Peppermint Oil to Reduce the Nausea of the 
Hospice Patient 
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                                                                                                      Total Number of 
Patients: 
  
Comments:      ___________________________________________________________ 
Gender Code:  1 for Male, 2 for Female 
Medication Codes:   1. Ativan 1-2 mg IV (Intravenous) or PO (by Mouth) 
           2. Phenergan 25mg PO    
                                 3. Zofran 16mg PO 
           4. Haldol 1-2mg PO 
                                 5. Peppermint Oil (1-2 drops on cotton ball) 
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